Tarsus Pharmaceuticals (TARS) Cash & Equivalents (2019 - 2023)
Tarsus Pharmaceuticals (TARS) reported Cash & Equivalents of $224.95 million for Q4 2023, up 213.9% from $71.66 million a year earlier.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Cash & Equivalents (2019 - 2023) Analysis & Trends
Dating back to Q3 2019, Tarsus Pharmaceuticals' Cash & Equivalents record includes 14 quarters.
- Cash & Equivalents has a four-year compound annual growth rate of 40.3% (FY2019 to FY2023).
- By year, Cash & Equivalents came in at $71.66 million in FY2022 (-58.2%), $171.33 million in FY2021 (+1.9%), $168.13 million in FY2020 (+189.9%) and $58 million in FY2019.
- The Q4 2023 figure ranks as the highest quarterly Cash & Equivalents since Q2 2022.
- Year over year, Cash & Equivalents gained in three of the last four quarters, with growth averaging 51.7%.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2021 (growth of 232.6%); the low point was Q4 2022 (a decline of 58.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Tarsus Pharmaceuticals | 3.16 Bn | 2.10 Bn | 161.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 224.95 Mn |
| Dec 31, 2022 | 71.66 Mn |
| Jun 30, 2022 | 245.40 Mn |
| Mar 31, 2022 | 175.01 Mn |
| Dec 31, 2021 | 171.33 Mn |
| Sep 30, 2021 | 183.80 Mn |
| Jun 30, 2021 | 176.74 Mn |
| Mar 31, 2021 | 156.18 Mn |
| Dec 31, 2020 | 168.13 Mn |
| Sep 30, 2020 | 86.33 Mn |
| Jun 30, 2020 | 53.14 Mn |
| Mar 31, 2020 | 55.89 Mn |
| Dec 31, 2019 | 58.00 Mn |
| Sep 30, 2019 | 337,000.00 |
API Access
Tarsus Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();